FSD Pharma Announces Decision To Surrender Health Canada Licenses For Subsidiary FV Pharma Inc.

FV Pharma to shut down operations within 30 days

CANADA: FSD Pharma Inc. today announced that it has notified Health Canada of the Company’s decision to forfeit the licenses of its wholly-owned subsidiary, FV Pharma, Inc.  and suspend all activities by FV Pharma within 30 days of the notification date. FSD Pharma has begun the process of liquidating all FV Pharma assets, including the sale of the Company’s cannabis production facility in Cobourg, Ontario.

“It is now clear to us that our shareholder value is best served in closing down our medicinal grade cannabis operation in Cobourg, Ontario and reinforcing steps to advance pharmaceutical R&D efforts on our lead compound FSD201 (ultra-micronized PEA) and continuing to explore the acquisition of other compelling compounds to expand our drug development pipeline,” said Raza Bokhari, MD, Executive Co-Chairman & CEO.

“Our pharmaceutical R&D team led by Dr. Edward Brennan is actively working to submit an Investigational New Drug Application (IND) to the FDA for the use of FSD201 (ultra-micronized PEA) to treat hospitalized COVID-19 patients by down-regulating the over-expressed pro-inflammatory cytokine immune response to SARS-CoV-2 virus infection. We are hopeful to initiate the phase 2 clinical trial before the end of this year and remain cautiously optimistic that our study may improve treatment outcome for COVID-19 patients.”

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.

CalCPA Cannabis Industry Symposium Examines Impact Of COVID-19, Regulation & Economic Outlook On CA’s $3 Billion Cannabis Sector

CALIFORNIA: COVID-19 has wreaked havoc on the California economy, and the cannabis sector has not been immune. Supply chains have been disrupted, revenues have taken a hit, and labor has been impacted. California’s cannabis industry is feeling the pain and seeking a path to recovery through economic stimulus, innovation and new business models, and solid advice from key advisors like CPAs who guide them through complex tax, accounting and auditing matters.

On August 7, 2020, CalCPA will again bring together leading experts and thinkers at its annual Cannabis Industry Virtual Symposium, where attendees will learn about the latest tax, legal and accounting updates impacting cannabis industry businesses and the professionals who advise them. Speakers will provide insight into new, recently implemented policies, outcomes from the COVID-19 stimulus legislation, interpretation of tax law, review of banking rules, trends in federal legislative actions, how to handle bankruptcy and receivership, and valuation of cannabis businesses.

Ohio Medical Marijuana Control Program Releases Testing Laboratory Provisional License Application Materials

OHIO:The Ohio Medical Marijuana Control Program (MMCP) is scheduled to accept new testing laboratory license applications beginning the week of August 3, 2020. On its testing laboratories webpage, the MMCP has posted two documents for potential applicants to assist in understanding the key substantive attributes of the application.

Potential applicants may submit questions regarding the application materials using instructions listed on the testing laboratories webpage. All questions must be submitted by July 31, 2020. The MMCP will then provide the frequently asked questions and MMCP answers to potential applicants.

For more information, visit the MMCP’s testing laboratories webpage.

FDA Issues Draft Guidance To Encourage Cannabis-Related Clinical Research

DISTRICT OF COLUMBIA:  The following quote is attributed to FDA Principal Deputy Commissioner Amy Abernethy M.D., Ph.D.:

“A range of stakeholders have expressed interest in development of drugs that contain cannabis and compounds found in cannabis. Recent legislative changes have also opened new opportunities for cannabis clinical research. As that body of research progresses and grows, the FDA is working to support drug development in this area.

“It is critical that the FDA continues to do what we can to support the science needed to develop new drugs from cannabis. The FDA believes the drug approval process represents the best way to ensure that safe and effective new medicines, including any drugs that contain cannabis or cannabis-derived compounds, are available to patients in need of appropriate medical therapy.

“The agency is committed to supporting the development of these new drugs through the investigational new drug, drug review and drug approval processes – and one key element of this support involves development of guidance, like this one.”

  • The U.S. Food and Drug Administration last week issued “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research, Draft Guidance for Industry,” which describes the FDA’s current thinking on several topics relevant to clinical research related to the development of drugs containing cannabis or cannabis-derived compounds.
  • The draft guidance covers sources of cannabis for clinical research, information on quality considerations and recommendations regarding calculating tetrahydrocannabinol (THC) levels.
  • The draft guidance also introduces key FDA regulatory concepts to stakeholders who may be less familiar with the FDA and the FDA’s authorities.

Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For June 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for June 2020. These numbers include:

  • 147,245 Recommendations
  • 116,497 Registered patients
    • 8,349 Patients with Veteran Status
    • 8,713 Patients with Indigent Status
    • 644 Patients with a Terminal Diagnosis
  • 91,330 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 13,140 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

NECANN Announces Largest Digital Cannabis Industry Event In The World

NECANN Online Debuts September 14-16

Three fall NECANN shows in VT, MA and NJ rescheduled to 2021

MASSACHUSETTS: The New England Cannabis Convention (NECANN) today announced it will host the largest Digital Cannabis Industry Event in the world September 14-16, while also rescheduling three fall conventions to new dates in 2021.

NECANN Online will feature over 500 exhibitors and 50-plus programming sessions covering all aspects of the industry. Participants will also receive a virtual swag bag and 2020 cannabis industry resource guide, and the all-digital event will feature live feeds from the 2020 New England Canna Community Awards Show and the NECANN Cannabis Competition Awards.

“As disappointed as we are to be moving three of our upcoming conventions into next year, we are incredibly excited to be presenting our exhibitors and attendees with NECANN Online, the largest and most content-packed digital event ever in the cannabis and hemp space”, said Marc Shepard, President of NECANN.

Programming will include four tracks running all three days, including expert speakers and panels from around the country speaking on technology & innovation, growing and extraction, business and careers, hemp, CBD, medical marijuana, and social justice & equity.

NECANN’s 2020 Burlington, VT, Springfield, MA and Atlantic City, NJ shows have been rescheduled to 2021. New dates are: May 29-30, 2021 for Burlington; June 19-20, 2021 for Springfield; and Sept. 10-11, 2021 for Atlantic City. NECANN’s 2020 conventions in Portland, ME, Chicago, IL and Boston, MA are still scheduled for respective dates in October, November and December.

“NECANN Online will feature much more than the virtual booths and webinars most shows present. We will have live awards shows, virtual gift bags and even a few surprise guests,” Shepard said.  In the meantime, we will continue to monitor the COVID 19 situation around the country and hope to be seeing everyone in-person again soon”.

 

NECANN 2020-21 Convention Schedule

NECANN ONLINE (Sep 14-16, 2020

 

Portland, Maine (October 17-18, 2020)

Chicago, IL (Nov. 20-21, 2020)

Boston, MA (Dec 10-12, 2020)

 

Burlington, VT (was Sept 29-27 2020), rescheduled to May 29-30, 2021

Springfield, MA (was Oct. 24-25, 2020), rescheduled to June 19-20, 2021

Atlantic City, NJ (was Sept 11-12, 2020), rescheduled to Sept 10-11, 2021

 

OLCC Marijuana Advisory Committee Meeting Is Thursday July 9, 2020

OREGON: The next OLCC Marijuana Advisory Committee Meeting will take place Thursday, July 9, 2020

Due to the outbreak of COVID-19, we are holding our meetings virtually. An audio recording of the meeting will be posted on our website.

You can listen live using your phone: 1 (872) 240-3311 Access Code: 786-241-877

 

Curved Papers Launches ‘Easy To Roll’ With Mike O’Malley On Sundays This Summer

By Michael O’Malley

As the Founder/CEO of Curved Papers, I’ve traveled the world and, along the way, taught a lot of people how to roll joints. I’ve also met some of the joint rolling virtuosos of the universe.

This summer on Sunday afternoons at 4:20pm EST, I’ll be going live on Zoom with some of my joint rolling friends, to teach novices in this ongoing tradition, known as Roll Your Own (RYO), which dates back centuries and millennia. Knowing how to Roll Your Own is still a big part of daily cannabis life, and the skill will serve you well over your life as a stoner…not to mention make you more popular at parties.

People learn from people, or they learn for themselves. Rolling joints is a nice thing, and over the years I’ve gotten teaching people how to roll down to a science. Well, it’s an art, I suppose.

But it’s like wine and weed, so much detail, and so many preferences. It’s a deep subject, and it touches on so many others, like many traditional practices.

‘Easy To Roll’ will start tomorrow (July 5, 2020) and I will host similar Zoom events every Sunday through Labor Day.

If you want to be on the Zoom call tomorrow or any Sunday, contact me (see below for my info).  Over the Summer many familiar faces from the blazing trail will pop in and show us their tricks. Tune in to see our surprise guest on the first episode tomorrow.

Otherwise, if you just want to follow along and learn a lot about rolling your own, the health benefits, the economics of it, the greenness and sustainability of it, the history of it and the cultures around it, tune in to @curvedpapers on FB and

As a special bonus, anyone who joins the call or comments on the FB or Instagram streams will be eligible to win a classic Curved Papers t-shirt, sure to make you the boss of your neighborhood, at the end of each month!

Curved Papers now offers seven popular styles, each with the Easy To Roll Curved Edge: White, brown, hemp and rice, and two popular sizes.

 


Michael O’Malley can be reached at: info@curvedpapers.com; @curvedpapers; www.curvedpapers.com

Virtual Listen and Learn Forum: Rules Regarding Tier 1 Producer Licensing, Session #2

WASHINGTON: The Washington State Liquor and Cannabis Board (WSLCB) is hosting two Listen and Learn forums about the current rules regarding marijuana producer licenses, specifically the consideration of revisions and new rule sections that would incrementally expand the plant canopy square footage allowed for licensed Tier 1 producers. This is the second of two planned sessions. Session #1 will cover WAC 314-55-075 Sections 1 through 5. Session #2 will focus on Sections 6 through 11.The full text of WAC 314-55-075 is provided here.

Please join us virtually on Tuesday, June 30, 2020, from 1:00 p.m. until 3:00 p.m. via WebEx in alignment with guidance and recommendations issued by the Governor’s office.

As you may recall, the Board began to consider revisions to existing producer license rules by initiating a formal rule inquiry on December 18, 2019. The Pre-proposal Statement of Inquiry filed by the Liquor and Cannabis Board may be found here.

The Board has received requests from medical marijuana patients and segments of the industry to increase the availability of Department of Health (DOH) compliant product in licensed retail stores. The Board has also learned that smaller producers are concerned about business sustainability based on canopy space restrictions. Recognizing this, the Board would like to explore the ways that it can support Tier 1 producer business viability. Revisions considered may also include clarifying and technical updates to existing rule within the scope of this topic.

An agenda is attached to help you prepare. Please come prepared to offer feedback and suggestions regarding this rule section.

If you wish to join us virtually, we’d like to offer the following reminders:

  • Virtual participation will be structured to allow one speaker at a time though the hand-raising feature on WebEx.
  • If you experience difficulty with audio or visual elements of virtual participation, please be patient.

Please remember that we are still in the developmental phase of rulemaking, and there are not yet any proposed or final rules amendments. To help you prepare for this listen/learn/contribute forum, please review the guidance document prepared for this and future forums.

Questions? Contact Casey Schaufler at casey.schaufler@lcb.wa.gov

To join the WebEx meeting online:

https://watech.webex.com/watech/onstage/g.php?MTID=e704a0de07d3b41806e1f7f59ba96195e

To join the WebEx meeting via audio conference only:

Toll Free: 1-855-929-3239
Access Code: 133 418 7301

Washington: WSLCB Virtual Listen and Learn Forum: Rules Regarding Tier 1 Producer Licensing, Session #1

WASHINGTON: The Washington State Liquor and Cannabis Board (WSLCB) is hosting two Listen and Learn forums about the current rules regarding marijuana producer licenses, specifically the consideration of revisions and new rule sections that would incrementally expand the plant canopy square footage allowed for licensed Tier 1 producers. This is the first of two planned sessions. Session #1 will cover WAC 314-55-075 Sections 1 through 5. Session #2 will focus on Sections 6 through 11. The full text of WAC 314-55-075 is provided here.

Please join us virtually on Tuesday, June 23, 2020, from 1:00 p.m. until 3:00 p.m. via WebEx in alignment with guidance and recommendations issued by the Governor’s office.

As you may recall, the Board began to consider revisions to existing producer license rules by initiating a formal rule inquiry on December 18, 2019. The Pre-proposal Statement of Inquiry filed by the Liquor and Cannabis Board may be found here.

The Board has received requests from medical marijuana patients and segments of the industry to increase the availability of Department of Health (DOH) compliant product in licensed retail stores. The Board has also learned that smaller producers are concerned about business sustainability based on canopy space restrictions. Recognizing this, the Board would like to explore the ways that it can support Tier 1 producer business viability. Revisions considered may also include clarifying and technical updates to existing rule within the scope of this topic.

An agenda is attached to help you prepare. Please come prepared to offer feedback and suggestions regarding this rule section.

If you wish to join us virtually, we’d like to offer the following reminders:

  • Virtual participation will be structured to allow one speaker at a time though the hand-raising feature on WebEx.
  • If you experience difficulty with audio or visual elements of virtual participation, please be patient.

Please remember that we are still in the developmental phase of rule-making, and there are not yet any proposed or final rules amendments. To help you prepare for this listen/learn/contribute forum, please review the guidance document prepared for this and future forums.

Questions? Contact Casey Schaufler at casey.schaufler@lcb.wa.gov

To join the WebEx meeting online:

https://watech.webex.com/watech/onstage/g.php?MTID=e1886460dce4a796b28a08402e1a194b6

To join the WebEx meeting via audio conference only:

Toll Free: 1-855-929-3239
Access Code: 133 082 7909